4.5 Article

Implementing Delirium Prevention in the Era of COVID-19

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 79, Issue 1, Pages 31-36

Publisher

IOS PRESS
DOI: 10.3233/JAD-200696

Keywords

Alzheimer's disease; COVID-19; dementia; hospitalization; quality of health care; tertiary care centers

Categories

Funding

  1. NIH [K07AG066813, UL1TR001427]

Ask authors/readers for more resources

Patients admitted with COVID-19 can develop delirium due to predisposing factors, isolation, and the illness itself. Standard delirium prevention methods focus on interaction and stimulation. It can be challenging to deliver these methods of care in COVID settings where it is necessary to increase patient isolation.
Patients admitted with COVID-19 can develop delirium due to predisposing factors, isolation, and the illness itself. Standard delirium prevention methods focus on interaction and stimulation. It can be challenging to deliver these methods of care in COVID settings where it is necessary to increase patient isolation. This paper presents a typical clinical vignette of representative patients in a tertiary care hospital and how a medical team modified an evidence-based delirium prevention model to deliver high-quality care to COVID-19 patients. The implemented model focuses on four areas of delirium-prevention: Mobility, Sleep, Cognitive Stimulation, and Nutrition. Future studies will be needed to track quantitative outcome measures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available